Cargando…

Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice

BACKGROUND: Inhibitors of the sodium‐glucose linked transporter 2 improve cardiovascular outcomes in patients with or without type 2 diabetes mellitus, but the effects on cardiac energetics and mitochondrial function are unknown. We assessed the effects of sodium‐glucose linked transporter 2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Croteau, Dominique, Luptak, Ivan, Chambers, Jordan M., Hobai, Ion, Panagia, Marcello, Pimentel, David R., Siwik, Deborah A., Qin, Fuzhong, Colucci, Wilson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403324/
https://www.ncbi.nlm.nih.gov/pubmed/34169737
http://dx.doi.org/10.1161/JAHA.120.019995
_version_ 1783745976912052224
author Croteau, Dominique
Luptak, Ivan
Chambers, Jordan M.
Hobai, Ion
Panagia, Marcello
Pimentel, David R.
Siwik, Deborah A.
Qin, Fuzhong
Colucci, Wilson S.
author_facet Croteau, Dominique
Luptak, Ivan
Chambers, Jordan M.
Hobai, Ion
Panagia, Marcello
Pimentel, David R.
Siwik, Deborah A.
Qin, Fuzhong
Colucci, Wilson S.
author_sort Croteau, Dominique
collection PubMed
description BACKGROUND: Inhibitors of the sodium‐glucose linked transporter 2 improve cardiovascular outcomes in patients with or without type 2 diabetes mellitus, but the effects on cardiac energetics and mitochondrial function are unknown. We assessed the effects of sodium‐glucose linked transporter 2 inhibition on mitochondrial function, high‐energy phosphates, and genes encoding mitochondrial proteins in hearts of mice with and without diet‐induced diabetic cardiomyopathy. METHODS AND RESULTS: Mice fed a control diet or a high‐fat, high‐sucrose diet received ertugliflozin mixed with the diet (0.5 mg/g of diet) for 4 months. Isolated mitochondria were assessed for functional capacity. High‐energy phosphates were assessed by (31)P nuclear magnetic resonance spectroscopy concurrently with contractile performance in isolated beating hearts. The high‐fat, high‐sucrose diet caused myocardial hypertrophy, diastolic dysfunction, mitochondrial dysfunction, and impaired energetic response, all of which were prevented by ertugliflozin. With both diets, ertugliflozin caused supernormalization of contractile reserve, as measured by rate×pressure product at high work demand. Likewise, the myocardial gene sets most enriched by ertugliflozin were for oxidative phosphorylation and fatty acid metabolism, both of which were enriched independent of diet. CONCLUSIONS: Ertugliflozin not only prevented high‐fat, high‐sucrose–induced pathological cardiac remodeling, but improved contractile reserve and induced the expression of oxidative phosphorylation and fatty acid metabolism gene sets independent of diabetic status. These effects of sodium‐glucose linked transporter 2 inhibition on cardiac energetics and metabolism may contribute to improved structure and function in cardiac diseases associated with mitochondrial dysfunction, such as heart failure.
format Online
Article
Text
id pubmed-8403324
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84033242021-09-03 Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice Croteau, Dominique Luptak, Ivan Chambers, Jordan M. Hobai, Ion Panagia, Marcello Pimentel, David R. Siwik, Deborah A. Qin, Fuzhong Colucci, Wilson S. J Am Heart Assoc Original Research BACKGROUND: Inhibitors of the sodium‐glucose linked transporter 2 improve cardiovascular outcomes in patients with or without type 2 diabetes mellitus, but the effects on cardiac energetics and mitochondrial function are unknown. We assessed the effects of sodium‐glucose linked transporter 2 inhibition on mitochondrial function, high‐energy phosphates, and genes encoding mitochondrial proteins in hearts of mice with and without diet‐induced diabetic cardiomyopathy. METHODS AND RESULTS: Mice fed a control diet or a high‐fat, high‐sucrose diet received ertugliflozin mixed with the diet (0.5 mg/g of diet) for 4 months. Isolated mitochondria were assessed for functional capacity. High‐energy phosphates were assessed by (31)P nuclear magnetic resonance spectroscopy concurrently with contractile performance in isolated beating hearts. The high‐fat, high‐sucrose diet caused myocardial hypertrophy, diastolic dysfunction, mitochondrial dysfunction, and impaired energetic response, all of which were prevented by ertugliflozin. With both diets, ertugliflozin caused supernormalization of contractile reserve, as measured by rate×pressure product at high work demand. Likewise, the myocardial gene sets most enriched by ertugliflozin were for oxidative phosphorylation and fatty acid metabolism, both of which were enriched independent of diet. CONCLUSIONS: Ertugliflozin not only prevented high‐fat, high‐sucrose–induced pathological cardiac remodeling, but improved contractile reserve and induced the expression of oxidative phosphorylation and fatty acid metabolism gene sets independent of diabetic status. These effects of sodium‐glucose linked transporter 2 inhibition on cardiac energetics and metabolism may contribute to improved structure and function in cardiac diseases associated with mitochondrial dysfunction, such as heart failure. John Wiley and Sons Inc. 2021-06-25 /pmc/articles/PMC8403324/ /pubmed/34169737 http://dx.doi.org/10.1161/JAHA.120.019995 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Croteau, Dominique
Luptak, Ivan
Chambers, Jordan M.
Hobai, Ion
Panagia, Marcello
Pimentel, David R.
Siwik, Deborah A.
Qin, Fuzhong
Colucci, Wilson S.
Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
title Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
title_full Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
title_fullStr Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
title_full_unstemmed Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
title_short Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
title_sort effects of sodium‐glucose linked transporter 2 inhibition with ertugliflozin on mitochondrial function, energetics, and metabolic gene expression in the presence and absence of diabetes mellitus in mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403324/
https://www.ncbi.nlm.nih.gov/pubmed/34169737
http://dx.doi.org/10.1161/JAHA.120.019995
work_keys_str_mv AT croteaudominique effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT luptakivan effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT chambersjordanm effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT hobaiion effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT panagiamarcello effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT pimenteldavidr effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT siwikdeboraha effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT qinfuzhong effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice
AT colucciwilsons effectsofsodiumglucoselinkedtransporter2inhibitionwithertugliflozinonmitochondrialfunctionenergeticsandmetabolicgeneexpressioninthepresenceandabsenceofdiabetesmellitusinmice